Know what to say when requesting GLP-1 options
In January 2024, the FDA announced it was investigating semaglutide for several potential safety signals, including blood clots, alongside hair loss, aspiration risk, and suicidal ideation
Tasty snacks and unhealthy fast foods seem to be everywhere
We believe in creating a realistic and enjoyable eating pattern that you can maintain in the long term, rather than resorting to restrictive diets that are difficult to sustain
Sustainable fat loss is one outcome, but the programme primarily targets metabolic health markers (HbA1c, fasting insulin, lipid profile, liver enzymes, blood pressure) and longevity indicators (visceral fat, sarcopenic muscle preservation, cardiovascular risk)